These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 965083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Use of potassium canrenoate in cardiosurgery].
    Tufano R, Scopa M, Brando G, Leone D.
    Minerva Anestesiol; 1981 Apr; 47(4):149-54. PubMed ID: 7242963
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M, Radaeli E, Ciaccio S, Corsini R, Trebbi R.
    Clin Ter; 1976 Feb 15; 76(3):215-34. PubMed ID: 963962
    [No Abstract] [Full Text] [Related]

  • 5. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
    Ruggerini R, Mazzocchi F, Albini G, Cifalinò M.
    Minerva Anestesiol; 1979 Sep 15; 45(9):687-90. PubMed ID: 117400
    [Abstract] [Full Text] [Related]

  • 6. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F, Remonda G, Morachioli N, Pugnani M.
    Ann Osp Maria Vittoria Torino; 1982 Sep 15; 25(1-6):61-70. PubMed ID: 7185311
    [Abstract] [Full Text] [Related]

  • 7. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study.
    Polderman KH, Girbes AR.
    Crit Care; 2004 Dec 15; 8(6):R459-66. PubMed ID: 15566592
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
    Capuani A, Bernabei M, Pasque A, Eufrate S.
    G Ital Cardiol; 1980 Dec 15; 10(9):1148-55. PubMed ID: 7461364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
    Costa FV, Borghi C, Mussi A, Ambrosioni E.
    Minerva Cardioangiol; 1988 Oct 15; 36(10):503-7. PubMed ID: 3226562
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M, Cuppone R, Ricci GL.
    Arzneimittelforschung; 1988 Oct 15; 38(10):1492-5. PubMed ID: 3058132
    [Abstract] [Full Text] [Related]

  • 14. [Potassium canreonate in neurosurgical brain edema].
    Mille T, Rodriguez R, Baena Y.
    Minerva Chir; 1988 Oct 15; 30(13-14):781-9. PubMed ID: 1221307
    [Abstract] [Full Text] [Related]

  • 15. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F, Ferraù O, Pitrone F, Luzza G, Russo A, Virga T.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S, Buch J.
    Eur J Cardiol; 1979 Aug 30; 10(2):143-9. PubMed ID: 477703
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M, Vizzini GB.
    Minerva Med; 1986 Jan 28; 77(3-4):87-91. PubMed ID: 3511409
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.